Miscellaneous
Currently, five chimeric antigen receptor T-cell (CAR-T) therapies are approved for the treatment of hematological malignancies including acute lymphoblastic leukemia,... The post IACH 2021: CAR-T in clinical practice appeared first on VJHemOnc.